Regeneron can’t dodge a lawsuit alleging it unlawfully inflated Medicare reimbursements for its eye drug Eylea and defrauded the US out of hundreds of millions …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Read Full Story: https://news.google.com/rss/articles/CBMiiAFBVV95cUxOVndsRWVuNGExaHdUb214MnZQ...